Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Dolasetron now available in U.S.

Feb. 25, 1998

Lead compound from ABS shows promise for neurodegenerative disorders

Feb. 25, 1998

Another market introduction for Aricept

Feb. 25, 1998

Biogen sets up Canadian office to promote local development of Avonex

Feb. 25, 1998

NOS inhibition with L-NMMA reduces CBF in humans

Feb. 25, 1998

C. pneumoniae antibody titers correlated to stroke and cerebral ischemia

Feb. 25, 1998

T Cell Sciences receives patent on new compound

Feb. 25, 1998

Apollo licenses technologies from U. of Florida

Feb. 24, 1998

Positive phase I results reported for TCAR product for MS

Feb. 24, 1998

CPMP recommends European approval of Exelon

Feb. 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...